GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary
Aevis Victoria SA (OTCPK:AEVIF)
[1]
Data Out of Date, Use Caution[5]$ 20.00
GF Score: 60/100Market Cap: $ 1,356 Mil
Industry: Healthcare - Healthcare Providers & Services
Aevis Victoria SA is a medical care company with five segments: Healthcare, Hospitality, Real Estate, Others, and Corporate. The Healthcare business segment operates private hospitals and clinics. The Hospitality business segment owns and operates hospitals. The Real Estate segment operates healthcare-related real estate properties. The Others segment provides ambulance services, such as... read more
Latest FY Operating Revenue by Business Segment
Business Segment Name2024Percentage
Health care768.1664.79%
Hospitality211.2717.82%
External services142.7412.04%
Corporate49.444.17%
Real estate34.602.92%
Others11.420.96%
Eliminations-31.93-2.69%
Financial Strength
Rank: 2 /10CurrentIndustry MedianHistorical Median
Cash-to-Debt0.030.7850.05
Equity-to-Asset0.270.490.25
Interest Coverage0.008.170.85
Piotroski F-Score655
Profitability Rank
Rank: 5 /10CurrentIndustry MedianHistorical Median
Operating Margin %-2.414.110.82
Net Margin %-0.281.84-0.21
ROE %-0.574.54-0.43
ROA %-0.151.36-0.10
ROC (Joel Greenblatt) %2.439.452.33
Growth Rank(* per share data)
Rank: 7 /1010-Yr5-Yr1-Yr
Revenue Growth %5.76.46.3
EBITDA Growth %1.6-9.581.8
Oprt. Income Growth %N/AN/AN/A
EPS w/o NRI Growth %N/AN/AN/A
FCF Growth %N/AN/AN/A
Book Value Growth %5.46.58.1
Momentum Rank
Rank: 1 /10CurrentIndustry MedianHistorical Median
5-Day RSIN/A55.12N/A
9-Day RSIN/A52.33N/A
14-Day RSIN/A50.82N/A
6-1M Momentum %N/A-2.90N/A
12-1M Momentum %N/A-6.63N/A
Quarterly
Dec22Jun23Dec23Jun24Dec24
Revenue594.56542.34537.19590.29541.53
Net Income13.68-11.96-32.99-0.89-2.33
EPS0.15-0.14-0.39-0.01--
Revenue YoY %42.6829.07-2.167.22-8.92
Net Income YoY %-175.86-186.2280.30-101.87-117.05
EPS YoY %-166.67-187.2781.11-101.94-100.00
Free Cash Flow47.38-49.32-25.04-38.3917.39
Cash & Equiv.80.9760.6793.3234.7841.41
Total Current Assets408.50372.48410.30345.24358.58
Short-Term Debt & CLO93.0112.08134.5839.52305.54
Total Current Liabilities358.22262.49428.23425.70627.63
Total Liabilities1,3751,4191,5231,4431,595
Stockholders Equity503.80509.94568.80547.04595.39
Warning Signs
SEVEREFinancial Strength: Poor
SEVEREAltman Z-Score: Distress
SEVEREAsset Growth: Faster than revenue growth
Good Signs
GOODBeneish M-Score: Unlikely manipulator
GF Value Rank
Rank: 8 /10CurrentIndustry MedianHistorical Median
PE RatioLoss23.72114.49
Forward P/E114.9421.77N/A
PB Ratio2.122.072.87
PS Ratio1.131.4951.45
P/FCFN/A16.365363.92
Shiller P/E70.7826.2278.95
PEG RatioN/A1.7819.44
Valuation Analysis
Current% of Price
EPV-41.88-209
NCAV-20.48-102
Tangible Book8.3142
Price20.00
Median PS Value25.72129
GF Value26.76134
Dividend & Ownership
Dividend Yield (TTM) %N/A
Dividend Yield (Forward) %N/A
Dividend Payout RatioN/A
Dividend Growth (5Y) %N/A
Yield on Cost (5Y) %N/A
Continuous Div. since2022
Insider Ownership %N/A
Institution Ownership %1.48
As of 07-01-2025
* All financial numbers are in millions except for per share data, ratios and percentage change. "Neg. E" means negative equity.
20152016201720182019202020212022202320242025Performance
%GainSP500
1W--1.79
1M--4.79
3M--10.10
6M--5.39
YTD--5.39
1Y--13.26
3Y--17.43
5Y--14.74
10Y--11.52
20.25
0.13
20.00
193
96.5
2015201620172018201920202021202220232024CurrentKey Data
----------------20.25--20.00Highest Stock Price
----------------20.00--20.00Lowest Stock Price
----------------1,685--1,356Market Cap
76.779.879.179.477.980.283.885.585.4----Shares Outstanding-Diluted
163.80457.14N/AN/A6.70N/AN/A25.36At LossN/AAt LossPE Ratio
----------------2.96--2.12PB Ratio
1.091.721.391.471.531.401.371.381.521.261.13PS Ratio
22.5828.3824.1527.046.9748.7724.3215.4844.7424.1622.82EV-to-EBITDA
2015201620172018201920202021202220232024TTMPer Share Data
7.557.298.498.359.2910.0611.4913.6612.9013.4513.36Revenue per Share
0.050.03-0.01-0.112.13-0.45-0.050.74-0.54---0.01Earnings per Share
-1.230.02-0.09-1.10-1.05-3.98-0.310.51-0.89-0.25-0.24Free Cash Flow per Share
--------------0.430.52----Dividends per Share
3.693.533.463.604.584.535.825.496.066.236.25Tangible Book per Share
----------------19.16--25.72Median PS Value
2.121.49----2.45----3.77------Graham Number
2015201620172018201920202021202220232024TTMIncome Statement
578.90581.32671.80662.57724.12806.79963.191,1681,1021,1331,132Revenue
465.83468.13539.41531.76571.24632.62763.98926.52865.12885.94884.78Gross Profit
80.4780.5380.2980.2678.8978.4179.3279.3378.5178.1778.17Gross Margin %
441.85437.28507.74514.95584.33672.43754.36919.10890.15913.27912.16Total Operating Expense
23.9830.8531.6716.81-13.09-39.819.627.42-25.03-27.34-27.37Operating Income
4.145.314.712.54-1.81-4.931.000.64-2.27-2.41-2.42Operating Margin %
3.792.27-0.93-8.73166.09-35.79-4.6363.13-45.44-3.22-3.22Net Income
0.650.39-0.14-1.3222.94-4.44-0.485.41-4.12-0.28-0.28Net Margin %
22.4728.1834.6624.95180.23-19.5326.7695.81-9.8133.8033.74EBIT
63.3270.5283.4478.80238.9543.2293.72167.2961.81108.75108.60EBITDA
1.310.75-0.30-2.7346.13-8.95-0.9912.24-8.47-0.55-0.56ROE %
0.280.15-0.05-0.4810.78-2.44-0.263.32-2.23-0.15-0.15ROA %
2015201620172018201920202021202220232024Dec24Balance Sheet
13.1324.5633.7434.6541.8173.7968.8680.9793.3241.4141.41Cash & Equivalents & MS
217.96228.44241.45268.65287.85348.23416.03408.50410.30358.58358.58Total Current Assets
1,3931,6871,7741,8701,2121,7221,8791,9222,1462,2482,248Total Assets
101.4923.52122.17166.2471.32196.80328.9593.01134.58305.54305.54Short-Term Debt & CLO
259.15176.27291.71345.40265.21432.72590.97358.22428.23627.63627.63Total Current Liabilities
723.92990.19945.56925.44432.83750.67584.47948.251,023895.71895.71Long-Term Debt & CLO
1,0911,3131,3911,421759.951,2501,2431,3751,5231,5951,595Total Liabilities
302.21304.82312.16326.88393.15406.61527.60503.80568.80595.39595.39Total Stockholders Equity
302.03374.24383.14448.66451.69472.36635.67547.59622.77652.84652.84Total Equity
2015201620172018201920202021202220232024TTMCashflow Statement
36.7654.5460.8916.5219.2026.7636.41122.6949.3452.1552.16Cash Flow from Operations
-113.14-220.50-57.78-91.73247.55-334.36-83.90-60.9141.12-69.85-69.77Cash Flow from Investing
40.78168.07-0.1191.53-260.74336.1345.17-48.87-84.36-31.47-31.43Cash Flow from Financing
-35.682.103.0216.315.9728.50-2.3312.896.10-49.16-49.02Net Change in Cash
13.1314.9218.4334.6540.9573.7968.8680.9793.3241.3641.36Ending Cash Position
-131.34-53.31-67.99-103.94-101.13-345.82-62.54-79.45-125.73-73.24-73.15Capital Expenditure
-94.581.23-7.11-87.42-81.93-319.07-26.1343.24-76.39-21.09-20.99Free Cash Flow
Competitor(* Up to 5 competitors are listed here. See full competitors list in the Competitive Comparison section below)
TickerCompanyMarket Cap
($M)
PE RatioGF Score
/100
Financial
Strength /10
Profitability
Rank /10
GF Value
Rank /10
Growth
Rank /10
Momentum
Rank /10
NYSE:CHEChemed Corp7,08023.5797998108
OTCPK:AEVIFAevis Victoria SA1,356At Loss6025871
XSWX:DOCMDocMorris AG410At Loss5042262
XSWX:ASCNAscom Holding AG16636.456986462
XSWX:SHLTNSHL Telemedicine Ltd39At Loss3853211
GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Financial Strength[2] (Quarterly data, as of Dec. 2024) : Poor (2/10)

0
1
2
3
4
5
6
7
8
9

Cash-to-Debt : 0.03

Cash-to-Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. A high ratio indicates that a company is better able to pay back its debt, and is thus able to take on more debt if necessary.


Equity-to-Asset : 0.27

Equity-to-Asset ratio is calculated as total stockholders equity divided by its total assets. Equity-to-Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity-to-Asset ratio (more leveraged) may have higher ROE % because of the leverage.


Debt-to-Equity : 2.02

A high Debt-to-Equity ratio generally means that a company has been aggressive in financing its growth with debt.


Piotroski F-Score : 6

The Piotroski F-Score is used to determine the strength of a firm's financial position, with 9 being the best and 0 being the worst.

0
1
2
3
4
5
6
7
8
9


WACC : 2.12% vs ROIC : -2.39%

The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. Return on invested capital (ROIC) measures how well a company generates cash flow relative to the capital it has invested in its business.


Dividend Yield : 0.00%

Dividend yield is a way to measure how much cash flow you are getting for each dollar invested in an equity position.

GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Profitability[3] (Annual data, as of Dec. 2024) : Fair (5/10)

0
1
2
3
4
5
6
7
8
9

Revenue : $542 Mil vs Net Income : $-2 Mil

Revenue is the amount of money that a company actually receives during a specific period, including discounts and deductions for returned merchandise. Net Income is a company's total profit. Net income is calculated by taking revenues and adjusting for the cost of doing business, depreciation, interest, taxes and other expenses.


Cash & Equivalents : $41 Mil vs Long-Term Debt* : $896 Mil

Cash & equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash. Long-Term Debt* consists of loans and obligations lasting over one year.


Operating Margin % : -7.64%

Operating margin % measures how much profit a company makes on a dollar of sales. Operating Margin % is calculated as Operating Income divided by Revenue.


EPS without NRI : $0.00

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock. In calculating earnings per share without non-recurring items, the dividends of preferred stocks and Non Operating Income need to subtracted from the total net income first.


Dividends per Share : $0.00

Dividends per Share is the amount of dividends that the shareholders of a company receive on a per-share basis. It is calculated using the total dividends paid out to shareholders over one fiscal year and the number of shares outstanding.


Free Cash Flow per Share : $0.21

Free Cash flow per Share is the amount of Free cash flow per outstanding share of the company's stock.

GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Valuation (Quarterly data, as of Dec. 2024)

These valuation metrics should give you a sense of reasonable prices, but be careful with them. Always seek to understand why a valuation is changing over time.


Valuation Chart (Current stock price : $20.00)


PE Ratio without NRI : At Loss

The price-to-earnings ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.


PB Ratio : 0.00

The price-to-book ratio measures the valuation of the stock relative to the underlying asset of the company.


PS Ratio : 1.26

The price-to-sales ratio is a valuation ratio that compares a company’s stock price to its revenues. The price-to-sales ratio is an indicator of the value placed on each dollar of a company’s sales or revenues.


Price-to-Free-Cash-Flow : 0.00

Price-to-free-cash-flow is very similar to the valuation metric of price-to-operating-cash-flow but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures from a company's total operating cash flow, thereby reflecting the actual cash flow available to fund non-asset-related growth.


EV-to-EBIT : 77.75

Enterprise value of a company divided by its trailing 12 months earnings before interest and taxes (EBIT).

GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Valuation Bands

In these charts the 10-year valuation bands of the price-to-earnings ratio (PE Ratio), price-to-book ratio (PB Ratio), price-to-sales ratio (PS Ratio) and price-to-operating-cash-flow ratio (POCF) are drawn together with the historical stock prices. For example, the upper line of the PE band is where the stock price would have been if it were always traded at the maximum PE ratio of the past 10 years. The lower line of the PE band is where the stock price would have been if it were always traded at the lowest PE ratio of the past 10 years. It is always better if the stock price is close to the lower line, which indicates a lower valuation.


Historical Price and PE Band


Historical Price and PS Band


Historical Price and PB Band


Historical Price and Price-to-Operating-Cash-Flow (POCF) Band

GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Warning Signs

GuruFocus conducted a thorough checkup using a checklist of 32 items that cover the areas of financial strength, profitability, growth, and valuation of each company. The purpose of Warning Signs is to warn you that the company may have red flags in certain areas, helping to avoid overlooking them. These warning signs do not necessarily mean you should not invest in the stock. But you should be aware of them before you invest.


Severe Warning Signs

Financial Strength : Poor

Aevis Victoria SA displays poor financial strength. Usually, this is caused by too much debt for the company.

Altman Z-Score : Distress

Altman Z-score of 1.1 is in distress zone. This implies bankruptcy possibility in the next two years.

Asset Growth : Faster than revenue growth

If a company builds assets at 9.9% a year, faster than its revenue growth rate of 6.4% over the past 5 years, it means that the company may be getting less efficient.

Good Signs

Beneish M-Score : Unlikely manipulator

Beneish M-Score -2.57 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Competitive Comparison


5 Year Price Change Comparison



Financial Strength

CompanyFinancial StrengthCash-to-DebtEquity-to-AssetDebt-to-EquityInterest CoveragePiotroski F-ScoreAltman Z-ScoreBeneish M-ScoreWACC %ROIC %
NYSE:CHEChemed Corp9/101.200.680.12232.78512.48-2.086.8420.98
XSWX:ASCNAscom Holding AG8/103.720.390.079.5043.14-2.876.312.88
BKK:BDMSBangkok Dusit Medical Services PCL8/100.660.680.1549.6876.01-2.617.8613.06
SZSE:300015Aier Eye Hospital Group Co Ltd7/101.050.630.3118.5247.74-2.6218.9216.48
NSE:APOLLOHOSPApollo Hospitals Enterprise Ltd6/100.380.400.964.9456.80-2.2613.0611.31
NAS:ENSGEnsign Group Inc6/100.170.411.0445.1673.59-2.277.618.15
BOM:543220Max Healthcare Institute Ltd6/100.250.620.329.03413.54-2.4311.769.18
NYSE:UHSUniversal Health Services Inc6/100.030.460.7510.2983.11-2.699.8510.89
SAU:4013Dr Sulaiman Al Habib Medical Services Group5/100.300.341.1810.8345.35-1.949.7614.60
NYSE:EHCEncompass Health Corp5/100.040.331.256.9083.51-2.858.4413.00
XTER:FMEFresenius Medical Care AG5/100.140.440.754.1071.83-2.707.243.71
XTER:FREFresenius SE & Co KGaA5/100.190.450.704.6281.39-2.447.213.21
BSP:RDOR3Rede d or Sao Luiz SA5/100.960.241.661.0271.91-2.7815.8110.01
XSWX:SHLTNSHL Telemedicine Ltd5/101.090.490.410.004-1.71-3.376.93-10.14
NYSE:THCTenet Healthcare Corp5/100.230.143.153.7761.91-2.779.4110.11
NYSE:DVADaVita Inc4/100.04-0.02-46.133.8571.74-2.977.009.89
XSWX:DOCMDocMorris AG4/100.310.440.920.0040.45-2.958.88-14.60
NYSE:HCAHCA Healthcare Inc4/100.02-0.06-13.205.1762.68-2.709.7117.72
XKLS:5225IHH Healthcare Bhd3/100.150.530.514.6062.42-2.515.976.34
OTCPK:AEVIFAevis Victoria SA2/100.030.272.020.0061.10-2.572.12-2.39
GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Competitive Comparison - Cont.


Profitability

CompanyProfitability RankOperating
Margin %
Net Margin %ROE %ROA %Price-to-Free-Cash-FlowROC (Joel Greenblatt) %3-Year Revenue Growth %3-Year EBITDA Growth %3-Year EPS w/o NRI Growth %
NYSE:HCAHCA Healthcare Inc10/1015.158.07Neg. E9.8620.2930.1814.707.007.90
NSE:APOLLOHOSPApollo Hospitals Enterprise Ltd9/1010.396.6319.157.62245.7624.4014.509.1011.10
BKK:BDMSBangkok Dusit Medical Services PCL9/1018.9914.8716.3310.8931.6720.8013.2015.1026.30
NYSE:CHEChemed Corp9/1015.7512.4026.0417.8923.16114.876.105.806.20
NYSE:DVADaVita Inc9/1015.016.63238.834.987.2533.3511.6011.402.00
NAS:ENSGEnsign Group Inc9/108.537.0017.696.7841.4713.1816.6013.4014.80
XKLS:5225IHH Healthcare Bhd9/1015.999.728.064.5356.9719.9512.4011.705.60
NYSE:UHSUniversal Health Services Inc9/1010.877.4418.258.3312.0123.0515.6013.5012.00
SZSE:300015Aier Eye Hospital Group Co Ltd8/1022.8116.9918.1511.3431.8251.1111.1014.00-5.70
SAU:4013Dr Sulaiman Al Habib Medical Services Group8/1020.6419.6133.2712.180.0018.9815.6017.4018.20
NYSE:EHCEncompass Health Corp8/1016.768.9725.327.6731.8824.259.509.4013.90
BOM:543220Max Healthcare Institute Ltd7/1021.1915.3112.148.00252.3632.0821.5022.2021.10
BSP:RDOR3Rede d or Sao Luiz SA7/1015.467.9516.854.169.7575.1330.2022.6049.30
XSWX:ASCNAscom Holding AG6/102.651.294.901.8929.3933.03-0.70-12.30-35.30
XTER:FMEFresenius Medical Care AG6/108.383.174.391.857.7821.453.10-3.40-13.30
XTER:FREFresenius SE & Co KGaA6/108.651.912.190.9715.0916.93-16.80-23.50-2.40
NYSE:THCTenet Healthcare Corp6/1014.927.0938.064.9912.1861.655.6027.8016.20
OTCPK:AEVIFAevis Victoria SA5/10-2.41-0.28-0.57-0.150.002.433.803.40-58.10
XSWX:SHLTNSHL Telemedicine Ltd3/10-12.45-49.44-47.35-28.730.00-223.34-1.50-26.00-45.40
XSWX:DOCMDocMorris AG2/10-10.25-9.56-24.93-11.400.00-101.20-21.6042.2026.10

Valuation

CompanyPE RatioPB RatioPS RatioPrice-to-Intrinsic-Value-Projected-FCFPrice-to-Intrinsic-Value-DCF (Earnings Based)Price-to-Median-PS-ValuePrice-to-Peter-Lynch-Fair-ValuePrice-to-Graham-NumberEarnings Yield (Joel Greenblatt) %Forward Rate of Return (Yacktman) %
OTCPK:AEVIFAevis Victoria SAAt Loss2.121.130.000.000.780.000.001.36-16.19
XSWX:DOCMDocMorris AGAt Loss0.480.160.000.000.000.000.00-15.390.00
XSWX:SHLTNSHL Telemedicine LtdAt Loss0.870.600.930.000.310.000.00-77.30-45.82
NYSE:UHSUniversal Health Services Inc10.601.820.760.780.740.761.101.4310.4714.84
NYSE:THCTenet Healthcare Corp11.733.940.830.830.004.070.580.0012.0827.78
NYSE:DVADaVita Inc14.540.000.930.650.940.911.350.007.9620.38
NYSE:HCAHCA Healthcare Inc17.320.001.391.430.651.351.080.007.6120.18
BSP:RDOR3Rede d or Sao Luiz SA19.413.131.532.520.000.000.532.2615.8121.20
BKK:BDMSBangkok Dusit Medical Services PCL20.533.193.061.621.640.621.831.906.1414.70
XTER:FMEFresenius Medical Care AG22.950.990.730.490.000.630.000.006.291.37
NYSE:CHEChemed Corp23.575.992.951.650.880.830.003.905.818.58
XKLS:5225IHH Healthcare Bhd24.841.972.411.232.850.681.493.005.7822.86
NYSE:EHCEncompass Health Corp24.885.632.242.742.231.793.794.896.008.86
NAS:ENSGEnsign Group Inc28.504.502.011.880.891.332.222.433.9015.17
SZSE:300015Aier Eye Hospital Group Co Ltd30.705.255.211.990.990.612.243.584.3716.85
XSWX:ASCNAscom Holding AG36.451.760.471.070.000.333.802.226.2914.40
SAU:4013Dr Sulaiman Al Habib Medical Services Group40.6312.957.980.000.000.002.104.912.5920.15
XTER:FREFresenius SE & Co KGaA56.041.241.090.690.001.400.002.565.78-11.69
NSE:APOLLOHOSPApollo Hospitals Enterprise Ltd72.0212.684.786.713.020.004.837.202.2115.43
BOM:543220Max Healthcare Institute Ltd115.8213.2117.7310.790.000.000.0013.511.240.00
GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Peter Lynch Chart[4]

GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Per Share Data


Per Share Data

Dec09
Dec10
Dec11
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Dec24
TTM Fiscal Period
4.19
6.42
6.85
7.65
8.10
7.54
7.55
7.29
8.49
8.35
9.29
10.06
11.49
13.66
12.90
13.45
13.36
Revenue per Share
0.34
0.51
0.68
0.75
1.06
0.88
0.83
0.88
1.06
0.99
3.07
0.54
1.12
1.96
0.72
1.29
1.28
EBITDA per Share
0.05
0.05
0.14
0.24
0.46
0.36
0.29
0.35
0.44
0.31
2.31
-0.24
0.32
1.12
-0.12
0.40
0.40
EBIT per Share
0.12
-0.24
0.02
0.07
0.15
0.08
0.05
0.03
-0.01
-0.11
2.13
-0.45
-0.05
0.74
-0.54
--
-0.01
Earnings per Share (Diluted)
0.12
-0.24
0.07
0.10
0.16
0.10
0.05
0.03
-0.06
-0.18
0.06
-0.61
-0.15
0.12
-0.55
--
-0.01
EPS without NRI
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-0.98
--
-0.29
Owner Earnings per Share (TTM)
-0.05
-0.07
-0.13
-1.24
-1.94
-0.56
-1.23
0.02
-0.09
-1.10
-1.05
-3.98
-0.31
0.51
-0.89
-0.25
-0.24
Free Cash Flow per Share
0.32
0.45
0.43
0.29
0.74
0.26
0.48
0.68
0.77
0.21
0.25
0.33
0.43
1.44
0.58
0.62
0.62
Operating Cash Flow per Share
0.22
0.23
0.44
0.17
0.45
0.69
0.18
0.33
0.44
0.45
0.52
0.89
0.82
0.96
1.11
0.49
0.49
Cash per Share
--
--
--
--
--
--
--
--
--
--
--
--
--
0.43
0.52
--
-- Dividends per Share
1.10
0.71
1.04
2.71
3.60
3.85
4.03
4.06
4.04
4.22
4.90
4.90
6.26
5.97
6.75
7.07
7.08
Book Value per Share
1.10
0.70
1.01
2.49
3.32
3.52
3.69
3.53
3.46
3.60
4.58
4.53
5.82
5.49
6.06
6.23
6.25
Tangible Book per Share
0.79
2.35
2.31
7.19
8.91
10.47
11.00
13.50
13.81
14.10
6.28
11.41
10.84
12.34
13.74
14.26
14.28
Total Debt per Share
--
--
--
--
--
--
--
--
--
--
--
--
--
--
20.00
--
20.00
Month End Stock Price
29.86
30.94
31.40
48.90
62.86
73.77
76.71
79.80
79.10
79.36
77.94
80.19
83.80
85.51
85.44
84.26
84.11
Shares Outstanding (Diluted Average)

Ratios

Dec09
Dec10
Dec11
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Dec24
TTM Fiscal Period
5.40
-26.29
1.73
3.48
4.53
2.21
1.31
0.75
-0.30
-2.73
46.13
-8.95
-0.99
12.24
-8.47
-0.55
-0.56
ROE %
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-2.86
--
-0.27
ROE % Adjusted to Book Value
2.98
-6.07
0.30
0.73
1.01
0.48
0.28
0.15
-0.05
-0.48
10.78
-2.44
-0.26
3.32
-2.23
-0.15
-0.15
ROA %
12.19
-26.39
1.77
3.75
4.92
2.40
1.43
0.84
-0.35
-3.20
51.36
-9.62
-1.07
13.24
-9.33
-0.62
-0.64
Return-on-Tangible-Equity
4.30
-6.07
0.30
0.74
1.03
0.49
0.28
0.15
-0.06
-0.49
11.04
-2.49
-0.26
3.39
-2.29
-0.15
-0.15
Return-on-Tangible-Asset
3.53
2.15
4.63
3.19
3.85
2.79
2.07
2.27
2.50
1.71
16.61
-2.20
2.35
8.04
-0.77
2.34
2.40
ROC (Joel Greenblatt) %
1.78
2.52
5.93
4.30
4.76
2.77
1.94
2.13
2.32
1.66
14.59
-1.75
2.08
6.72
-0.60
2.02
2.04
ROCE %
--
--
--
--
35.42
468
6.94
-7.14
-54.79
-524
99.75
-30.37
-2.48
46.78
-308
-34.47
-34.47
5-Year RORE %
0.82
0.04
4.48
2.46
-1.31
11.03
96.53
-63.83
-14.70
32.42
7.93
-4.36
14.79
0.72
-21.75
-6.69
-6.69
1-Year ROIIC %
1.64
1.69
2.05
3.94
1.76
2.31
14.74
1.24
0.28
2.60
-0.98
-2.63
0.46
0.38
-1.30
-2.30
-2.37
ROIC %
4.59
3.07
0.54
0.63
0.76
0.39
1.66
1.68
0.42
1.78
-0.20
1.70
1.89
3.32
2.04
0.65
2.12
WACC %
6.30
4.52
3.88
3.03
2.97
2.95
2.79
2.57
2.56
2.54
2.26
2.58
2.25
2.50
3.69
3.30
4.61
Effective Interest Rate on Debt %
75.72
73.58
72.04
69.51
80.01
80.07
80.47
80.53
80.29
80.26
78.89
78.41
79.32
79.33
78.51
78.17
78.17
Gross Margin %
1.08
0.72
4.11
4.86
5.92
5.11
4.14
5.31
4.71
2.54
-1.81
-4.93
1.00
0.64
-2.27
-2.41
-2.42
Operating Margin %
2.89
-3.70
0.23
0.97
1.91
1.06
0.65
0.39
-0.14
-1.32
22.94
-4.44
-0.48
5.41
-4.12
-0.28
-0.28
Net Margin %
8.08
7.87
9.89
9.85
13.12
11.69
10.94
12.13
12.42
11.89
33.00
5.36
9.73
14.32
5.61
9.60
9.60
EBITDA Margin %
-1.25
-1.10
-1.91
-16.27
-24.00
-7.44
-16.34
0.21
-1.06
-13.19
-11.31
-39.55
-2.71
3.70
-6.93
-1.86
-1.85
FCF Margin %
0.72
3.31
2.23
2.66
2.48
2.72
2.73
3.33
3.42
3.34
1.28
2.33
1.73
2.07
2.04
2.02
2.02
Debt-to-Equity
0.37
0.15
0.19
0.21
0.23
0.21
0.22
0.18
0.18
0.18
0.32
0.24
0.28
0.26
0.27
0.27
0.27
Equity-to-Asset
0.26
0.49
0.43
0.57
0.57
0.57
0.59
0.60
0.60
0.58
0.42
0.55
0.49
0.54
0.54
0.53
0.53
Debt-to-Asset
0.63
0.85
0.81
0.78
0.77
0.75
0.78
0.78
0.78
0.76
0.63
0.73
0.66
0.72
0.71
0.71
0.71
Liabilities-to-Assets
77.97
121
91.36
52.67
42.35
36.39
34.33
30.40
31.17
29.19
37.07
43.13
42.43
48.75
42.53
40.33
41.24
Gross-Profit-to-Asset %
-33.83
500
-0.54
2.01
0.73
-42.82
2.52
-1.54
-7.49
-29.52
-3.25
1.09
0.36
-5.64
1.54
0.21
0.21
Degree of Financial Leverage
1.03
1.64
1.27
0.76
0.53
0.46
0.43
0.38
0.39
0.36
0.47
0.55
0.54
0.62
0.54
0.52
0.53
Asset Turnover
--
--
--
--
--
--
--
--
--
--
--
--
--
3.73
--
--
-- Dividend Payout Ratio
64.89
54.32
70.08
68.06
73.96
70.32
67.82
70.62
62.11
66.74
66.49
66.41
65.38
56.44
60.67
63.63
62.10
Days Sales Outstanding
290
199
230
170
263
248
254
290
271
299
252
237
243
224
250
263
246
Days Payable
52.26
40.46
42.80
31.82
50.71
53.63
55.70
58.75
54.52
58.64
57.94
63.20
63.58
53.92
57.47
56.55
57.07
Days Inventory
-173
-105
-117
-70.03
-138
-124
-131
-161
-155
-174
-127
-107
-114
-114
-132
-142
-127
Cash Conversion Cycle
5.63
6.72
5.21
5.36
4.94
5.19
5.38
5.17
5.88
5.47
5.49
5.50
5.58
6.47
6.02
5.74
5.88
Receivables Turnover
6.98
9.02
8.53
11.47
7.20
6.81
6.55
6.21
6.69
6.22
6.30
5.78
5.74
6.77
6.35
6.45
6.40
Inventory Turnover
0.24
0.26
0.28
0.30
0.20
0.20
0.20
0.19
0.20
0.20
0.21
0.22
0.21
0.21
0.21
0.22
0.22
COGS-to-Revenue
0.04
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.04
0.04
0.03
0.03
0.03
0.03
Inventory-to-Revenue
0.09
0.08
0.08
0.20
0.33
0.11
0.23
0.09
0.10
0.16
0.14
0.43
0.07
0.07
0.11
0.07
0.07
Capex-to-Revenue
8.25
11.41
2.00
4.13
5.60
2.13
5.48
1.73
2.15
6.18
--
--
6.50
10.71
--
--
-- Capex-to-Operating-Income
1.16
1.16
1.30
5.27
3.62
3.17
3.57
0.98
1.12
6.29
5.27
12.93
1.72
0.65
2.55
1.40
1.40
Capex-to-Operating-Cash-Flow
* All financial numbers are in millions except for per share data, ratios and percentage change. When Return-on-Tangible-Equity displays Neg. E, it means the the tangible equity is negative. When ROE % or ROE % Adjusted to Book Value displays Neg. E, it means the the total shareholders equity is negative.
GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Financial Statement

Income Statement

Dec09
Dec10
Dec11
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Dec24
TTM Fiscal Period
125
199
215
374
509
556
579
581
672
663
724
807
963
1,168
1,102
1,133
1,132
Revenue
30.37
52.46
60.15
114
102
111
113
113
132
131
153
174
199
241
237
247
247
Cost of Goods Sold
94.70
146
155
260
407
445
466
468
539
532
571
633
764
927
865
886
885
Gross Profit
75.72
73.58
72.04
69.51
80.01
80.07
80.47
80.53
80.29
80.26
78.89
78.41
79.32
79.33
78.51
78.17
78.17
Gross Margin %
--
--
9.25
17.70
27.78
34.69
33.84
29.93
36.73
42.11
44.73
47.51
48.49
53.45
50.26
53.76
-- Selling, General, & Admin. Expense
93.35
145
137
224
349
382
408
407
471
473
540
625
706
866
840
860
912
Other Operating Expense
93.35
145
146
242
377
417
442
437
508
515
584
672
754
919
890
913
912
Total Operating Expense
1.35
1.42
8.84
18.17
30.14
28.43
23.98
30.85
31.67
16.81
-13.09
-39.81
9.62
7.42
-25.03
-27.34
-27.37
Operating Income
1.08
0.72
4.11
4.86
5.92
5.11
4.14
5.31
4.71
2.54
-1.81
-4.93
1.00
0.64
-2.27
-2.41
-2.42
Operating Margin %
0.02
--
0.09
0.95
0.78
0.84
0.65
0.83
0.94
1.10
1.08
1.26
1.70
0.82
1.43
1.35
1.35
  Interest Income
-1.37
-2.20
-2.98
-8.10
-16.22
-20.55
-21.99
-23.67
-26.62
-27.37
-18.07
-18.75
-20.91
-24.42
-40.56
-38.93
-38.89
  Interest Expense
-1.37
-2.20
-3.32
-8.86
-17.16
-21.02
-23.06
-24.51
-27.10
-25.30
-18.93
-18.66
-18.62
-25.99
-36.36
-41.32
-41.27
Net Interest Income
2.92
-5.00
-4.11
-5.78
-0.32
-1.23
-0.43
-1.83
3.47
6.06
194
20.19
14.85
89.97
11.02
63.52
63.51
Other Income (Expense)
2.89
-5.78
1.41
3.53
12.67
6.18
0.48
4.51
8.04
-2.43
162
-38.28
5.85
71.40
-50.37
-5.14
-5.14
Pre-Tax Income
0.72
-1.57
-0.90
0.62
-4.86
-0.14
3.28
-1.87
-6.88
-4.24
14.61
3.55
-0.89
-5.02
1.97
-4.21
-4.21
Tax Provision
-25.03
-27.22
64.13
-17.53
38.36
2.28
-681
41.48
85.60
-175
-9.01
9.28
15.19
7.04
3.90
-81.93
-81.83
Tax Rate %
--
--
0.00
--
0.00
-0.00
0.00
0.00
-0.00
--
0.00
-0.00
-0.00
--
-0.00
--
-0.00
Other Net Income (Loss)
3.62
-7.35
0.51
4.15
7.81
6.03
3.77
2.64
1.16
-6.67
177
-34.73
4.96
66.37
-48.40
-9.34
-9.35
Net Income Including Noncontrolling Interests
3.62
-7.35
0.51
4.15
7.81
6.03
3.77
2.64
1.16
-6.67
177
-34.73
4.96
66.37
-48.40
-9.34
-9.35
  Net Income (Continuing Operations)
2.92
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--   Net Income (Discontinued Operations)
--
--
--
-0.54
1.90
-0.13
0.02
-0.38
-2.09
-2.06
-10.68
-1.06
-9.59
-3.24
2.97
6.12
6.13
Other Income (Minority Interest)
3.62
-7.35
0.51
3.61
9.71
5.90
3.79
2.27
-0.93
-8.73
166
-35.79
-4.63
63.13
-45.44
-3.22
-3.22
Net Income
2.89
-3.70
0.23
0.97
1.91
1.06
0.65
0.39
-0.14
-1.32
22.94
-4.44
-0.48
5.41
-4.12
-0.28
-0.28
Net Margin %
0.12
-0.24
0.02
0.07
0.15
0.08
0.05
0.03
-0.01
-0.11
2.13
-0.45
-0.05
0.75
-0.54
--
-0.01
EPS (Basic)
0.12
-0.24
0.02
0.07
0.15
0.08
0.05
0.03
-0.01
-0.11
2.13
-0.45
-0.05
0.74
-0.54
--
-0.01
EPS (Diluted)
29.86
30.94
31.40
48.90
62.86
73.77
76.71
79.80
79.10
79.36
77.94
80.19
83.80
85.51
85.44
84.26
84.11
Shares Outstanding (Diluted Average)
1.35
1.42
4.39
11.63
28.89
26.73
22.47
28.18
34.66
24.95
180
-19.53
26.76
95.81
-9.81
33.80
33.74
EBIT
8.76
14.21
16.90
25.21
37.87
38.26
40.85
42.34
48.78
53.85
58.73
62.75
66.96
71.48
71.62
74.95
74.86
Depreciation, Depletion and Amortization
10.10
15.64
21.29
36.84
66.75
64.98
63.32
70.52
83.44
78.80
239
43.22
93.72
167
61.81
109
109
EBITDA
8.08
7.87
9.89
9.85
13.12
11.69
10.94
12.13
12.42
11.89
33.00
5.36
9.73
14.32
5.61
9.60
9.60
EBITDA Margin %
* All financial numbers are in millions except for per share data, ratios and percentage change.
GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Financial Statement

Cashflow Statement

Dec09
Dec10
Dec11
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Dec24
TTM Fiscal Period
3.62
-7.35
0.51
3.61
9.71
5.90
3.77
2.64
1.16
-6.67
177
-34.73
4.96
66.37
-48.40
-9.34
-9.35
Net Income From Continuing Operations
8.76
14.21
16.90
25.21
37.87
38.26
40.85
42.34
48.78
53.85
58.73
62.75
66.96
71.48
71.62
74.95
74.86
Depreciation, Depletion and Amortization
3.61
-2.09
-12.73
-21.23
-21.57
-7.99
-19.99
8.60
4.23
-25.02
-3.09
5.50
-28.36
30.50
24.76
21.10
21.11
  Change In Receivables
-0.40
-0.44
-0.17
-2.19
-1.15
-0.20
-0.22
1.33
-1.54
-0.64
-2.64
-2.38
-0.70
-0.72
-1.77
1.48
1.48
  Change In Inventory
-2.51
4.42
7.31
1.72
28.52
-13.83
19.46
-1.46
10.64
4.05
1.76
10.41
-2.12
28.21
5.46
23.27
23.34
  Change In Other Working Capital
0.70
1.90
-5.59
-21.70
5.81
-22.02
-0.74
8.47
13.32
-21.61
-3.96
13.53
-31.18
57.98
28.45
45.85
45.93
Change In Working Capital
--
--
0.90
-0.62
4.86
--
--
--
--
--
--
--
--
--
--
--
-- Deferred Tax
0.25
--
--
--
--
0.37
0.35
0.54
0.44
0.34
0.33
--
--
0.57
0.81
0.78
0.78
Stock Based Compensation
-3.78
5.28
0.87
7.76
-11.59
-3.41
-7.47
0.56
-2.81
-9.39
-213
-14.80
-4.33
-73.71
-3.13
-60.09
-60.07
Cash Flow from Others
9.55
14.04
13.59
14.26
46.65
19.10
36.76
54.54
60.89
16.52
19.20
26.76
36.41
123
49.34
52.15
52.16
Cash Flow from Operations
-11.11
-15.90
-16.26
-72.20
-166
-57.56
-125
-45.05
-55.95
-91.51
-92.86
-333
-45.74
-59.57
-99.97
-37.83
-37.78
Purchase Of Property, Plant, Equipment
--
--
--
--
--
1.55
28.60
0.42
0.15
0.17
0.03
42.96
0.50
0.08
0.12
--
-- Sale Of Property, Plant, Equipment
-0.63
-18.47
--
-57.31
-54.42
-44.33
-17.91
-124
-0.32
-2.15
-30.12
--
-10.51
-19.21
-5.38
--
-0.84
Purchase Of Business
2.25
1.03
--
--
--
0.07
--
0.00
--
--
383
0.71
4.19
--
14.50
0.53
-- Sale Of Business
-0.13
--
-6.98
-2.11
-1.75
--
--
-46.38
-19.45
-14.04
-11.55
-39.36
-136
-36.26
-11.87
-3.70
-3.69
Purchase Of Investment
--
--
--
--
--
--
7.51
2.88
29.84
28.23
6.87
7.16
120
73.93
0.47
78.40
78.39
Sale Of Investment
--
-0.32
-1.45
-2.89
-2.46
-2.94
-6.33
-8.26
-12.04
-12.42
-8.27
-12.61
-16.80
-19.89
-25.71
-35.41
-35.37
Net Intangibles Purchase And Sale
3.20
-0.41
-0.00
-0.00
0.00
0.00
0.00
0.00
-0.00
0.00
-0.00
0.00
-0.00
-0.00
169
-71.85
-70.47
Cash From Other Investing Activities
-6.42
-34.07
-24.68
-134
-225
-103
-113
-221
-57.78
-91.73
248
-334
-83.90
-60.91
41.12
-69.85
-69.77
Cash Flow from Investing
0.11
0.32
16.59
1.11
51.56
1.07
--
2.67
13.60
3.39
15.76
--
--
--
0.02
--
-- Issuance of Stock
-0.19
-0.08
--
-2.13
-14.41
-4.16
-0.92
-11.15
-2.33
-5.45
--
-7.14
-2.08
-1.34
-4.66
-2.81
-2.81
Repurchase of Stock
2.28
30.68
9.60
176
167
176
61.94
291
3.11
156
18.16
405
123
352
--
--
--   Issuance of Debt
-0.49
-7.23
-2.14
-56.68
--
--
-2.18
-107
--
-139
-194
-61.91
-163
-508
--
--
--   Payments of Debt
1.79
23.46
7.46
119
167
176
59.76
184
3.11
17.33
-176
344
-40.18
-156
--
--
-- Net Issuance of Debt
--
--
--
--
-4.20
-8.02
-7.71
-7.95
-8.44
-8.42
-75.14
--
--
-90.61
-73.06
--
-- Cash Flow for Dividends
-3.09
-3.71
-5.07
-5.11
--
--
--
--
--
--
--
--
--
--
--
--
-- Cash Flow for Lease Financing
--
--
--
2.20
-0.31
-60.29
-10.36
0.05
-6.05
84.69
-25.29
-0.24
87.43
199
-6.66
-28.66
-28.62
Other Financing
-1.38
19.99
18.98
115
200
104
40.78
168
-0.11
91.53
-261
336
45.17
-48.87
-84.36
-31.47
-31.43
Cash Flow from Financing
4.98
7.15
7.37
15.46
10.97
29.80
48.81
12.82
15.41
18.34
34.98
45.29
71.18
68.07
87.22
90.52
90.38
Beginning Cash Position
--
--
--
--
-0.15
-0.01
-0.08
-0.01
0.02
-0.01
-0.04
-0.02
--
-0.02
-0.01
0.01
0.01
  Effect of Exchange Rate Changes
1.75
-0.05
7.88
-4.83
21.57
20.00
-35.68
2.10
3.02
16.31
5.97
28.50
-2.33
12.89
6.10
-49.16
-49.02
Net Change in Cash
6.73
7.10
15.26
10.63
32.54
49.80
13.13
14.92
18.43
34.65
40.95
73.79
68.86
80.97
93.32
41.36
41.36
Ending Cash Position
-11.11
-16.22
-17.70
-75.08
-169
-60.50
-131
-53.31
-67.99
-104
-101
-346
-62.54
-79.45
-126
-73.24
-73.15
Capital Expenditure
-1.56
-2.18
-4.11
-60.83
-122
-41.39
-94.58
1.23
-7.11
-87.42
-81.93
-319
-26.13
43.24
-76.39
-21.09
-20.99
Free Cash Flow
* All financial numbers are in millions except for per share data, ratios and percentage change.
GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Financial Satement

Balance Sheet

Dec09
Dec10
Dec11
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Dec24
TTM Fiscal Period
6.73
7.10
15.26
10.63
32.54
49.80
13.13
14.92
18.43
34.65
40.95
73.79
68.86
80.97
93.32
41.36
41.36
  Cash And Cash Equivalents
--
--
--
--
--
--
--
9.64
15.31
--
0.86
--
--
--
--
0.05
0.05
  Marketable Securities
6.73
7.10
15.26
10.63
32.54
49.80
13.13
24.56
33.74
34.65
41.81
73.79
68.86
80.97
93.32
41.41
41.41
Cash, Cash Equivalents, Marketable Securities
22.49
36.61
46.01
93.40
113
101
114
111
117
125
139
155
190
171
196
200
200
  Accounts Receivable
5.11
5.24
12.92
30.73
48.47
64.89
73.52
73.82
69.57
87.81
79.88
86.72
120
122
81.87
80.50
80.50
  Other Current Receivables
27.60
41.85
58.93
124
161
166
187
185
187
213
219
241
311
293
277
280
280
Total Receivables
--
5.20
5.11
8.26
11.82
10.69
11.57
12.44
13.47
13.81
15.12
17.99
18.34
18.00
20.26
19.23
19.23
  Inventories, Raw Materials & Components
--
1.31
1.13
2.97
2.12
2.98
3.10
3.26
4.40
4.70
5.36
7.82
9.36
7.55
8.23
8.77
8.77
  Inventories, Finished Goods
4.79
0.32
1.03
1.37
1.74
3.24
2.92
3.14
2.84
2.81
6.74
7.29
8.61
9.46
11.05
9.11
9.11
  Inventories, Other
4.79
6.84
7.27
12.60
15.67
16.91
17.60
18.84
20.71
21.32
27.21
33.10
36.30
35.01
39.54
37.11
37.11
Total Inventories
3.15
2.66
0.00
-0.00
--
--
0.00
-0.00
0.00
-0.00
0.00
--
-0.00
-0.00
--
0.00
0.00
Other Current Assets
42.26
58.45
81.45
147
210
233
218
228
241
269
288
348
416
408
410
359
359
Total Current Assets
--
--
--
465
657
825
878
1,058
1,097
1,114
238
567
668
683
803
947
947
  Land And Improvements
30.52
--
94.14
156
237
334
365
399
451
468
495
633
647
659
734
734
734
  Buildings And Improvements
37.67
59.73
66.47
122
143
157
175
216
245
265
288
360
392
403
474
497
497
  Machinery, Furniture, Equipment
--
8.46
2.06
10.19
5.37
10.65
9.52
15.45
17.74
52.69
70.04
8.17
16.09
8.14
17.76
13.25
13.25
  Construction In Progress
--
62.48
0.00
-0.00
3.99
4.66
6.25
6.56
6.92
7.04
6.53
8.16
4.43
4.60
6.02
5.93
5.93
  Other Gross PPE
68.19
131
163
754
1,046
1,331
1,434
1,694
1,818
1,907
1,098
1,576
1,728
1,757
2,035
2,198
2,198
Gross Property, Plant and Equipment
-22.85
-43.51
-60.27
-131
-171
-290
-302
-343
-392
-422
-412
-490
-532
-570
-667
-677
-677
  Accumulated Depreciation
45.34
87.16
102
623
876
1,041
1,132
1,352
1,426
1,485
686
1,086
1,196
1,188
1,368
1,520
1,520
Property, Plant and Equipment
--
0.21
0.99
13.89
19.93
23.94
25.62
39.48
44.97
48.16
25.17
30.32
37.52
40.37
58.23
70.16
70.16
Intangible Assets
4.98
3.96
4.66
12.96
20.54
23.32
17.60
67.40
61.49
68.50
213
257
230
286
309
299
299
Other Long Term Assets
50.31
91.33
108
650
916
1,088
1,175
1,459
1,532
1,601
924
1,374
1,463
1,514
1,736
1,889
1,889
Total Long-Term Assets
92.58
150
190
797
1,126
1,321
1,393
1,687
1,774
1,870
1,212
1,722
1,879
1,922
2,146
2,248
2,248
Total Assets
23.51
33.79
42.03
64.09
82.49
68.25
89.41
90.61
106
108
102
124
142
155
169
187
187
  Accounts Payable
--
--
0.17
5.64
4.94
3.60
3.23
4.41
3.05
3.72
2.40
17.45
14.07
1.96
2.01
2.99
2.99
  Total Tax Payable
--
--
4.75
3.48
-0.00
--
0.00
0.00
--
--
--
0.00
--
--
0.00
-0.00
-0.00
  Other Current Payables
23.51
33.79
46.96
73.20
87.43
71.85
92.64
95.03
109
112
105
141
156
157
171
190
190
Accounts Payable & Accrued Expense
14.20
24.44
38.27
229
233
13.75
95.68
15.11
111
154
58.37
181
315
82.21
122
292
292
  Short-Term Debt
2.41
4.47
4.88
4.11
5.43
6.84
5.81
8.41
11.01
12.04
12.95
15.41
13.73
10.80
12.96
13.71
13.71
  Short-Term Capital Lease Obligation
16.61
28.91
43.15
233
239
20.59
101
23.52
122
166
71.32
197
329
93.01
135
306
306
Short-Term Debt & Capital Lease Obligation
8.79
17.72
20.79
29.59
48.35
50.75
65.01
57.72
60.33
67.02
89.08
94.96
106
109
122
132
132
Other Current Liabilities
48.90
80.42
111
336
374
143
259
176
292
345
265
433
591
358
428
628
628
Total Current Liabilities
1.82
33.08
28.89
214
395
726
714
974
924
500
414
730
567
936
999
869
869
  Long-Term Debt
5.95
10.77
8.81
6.99
5.17
6.52
10.22
15.89
21.40
425
18.38
20.91
17.68
12.17
24.46
26.86
26.86
  Long-Term Capital Lease Obligation
7.77
43.85
37.69
221
400
733
724
990
946
925
433
751
584
948
1,023
896
896
Long-Term Debt & Capital Lease Obligation
0.72
3.31
2.23
2.66
2.48
2.72
2.73
3.33
3.42
3.34
1.28
2.33
1.73
2.07
2.04
2.02
2.02
Debt-to-Equity
1.95
3.54
4.65
65.16
90.79
118
108
146
153
151
61.92
66.39
67.75
68.14
71.36
71.69
71.69
Other Long-Term Liabilities
9.72
47.38
42.35
286
491
851
832
1,137
1,099
1,076
495
817
652
1,016
1,095
967
967
Total Long-Term Liabilities
58.62
128
153
622
865
994
1,091
1,313
1,391
1,421
760
1,250
1,243
1,375
1,523
1,595
1,595
Total Liabilities
30.10
32.00
37.92
69.18
80.26
73.80
75.55
74.22
79.12
79.23
81.82
93.99
91.78
90.74
97.74
94.81
94.81
Common Stock
0.08
-7.50
-7.32
-4.40
5.79
10.78
24.14
25.70
25.64
52.38
219
206
297
312
358
344
344
Retained Earnings
6.64
0.05
115
223
268
--
--
--
--
--
--
--
--
--
--
--
-- Additional Paid-In Capital
-2.86
-2.56
-2.57
-3.72
-0.39
-0.25
-1.08
-5.52
-8.25
-13.69
-0.88
-6.05
-4.00
-2.20
-5.54
-8.06
-8.06
Treasury Stock
--
--
-107
-113
-96.15
193
204
210
216
209
93.25
112
143
104
119
165
165
Other Stockholders Equity
33.96
21.98
36.26
171
258
277
302
305
312
327
393
407
528
504
569
595
595
Total Stockholders Equity
--
--
--
4.36
3.01
49.98
-0.18
69.43
70.98
122
58.54
65.74
108
43.79
53.98
57.45
57.45
Minority Interest
33.96
21.98
36.26
175
261
327
302
374
383
449
452
472
636
548
623
653
653
Total Equity
0.37
0.15
0.19
0.21
0.23
0.21
0.22
0.18
0.18
0.18
0.32
0.24
0.28
0.26
0.27
0.27
0.27
Equity-to-Asset
* All financial numbers are in millions except for per share data, ratios and percentage change.
GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Valuation Ratios

Valuation Ratios

Dec09
Dec10
Dec11
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Dec24
TTM Fiscal Period
24.11
N/A
248
82.35
48.12
115
164
457
N/A
N/A
6.70
N/A
N/A
25.36
At Loss
N/A
At Loss PE Ratio
24.11
N/A
62.86
62.22
47.77
92.78
155
441
N/A
N/A
246
N/A
N/A
164
At Loss
N/A
At Loss PE Ratio without NRI
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2.96
--
2.12
PB Ratio
--
--
--
--
--
--
--
--
--
--
--
--
--
--
3.30
--
2.41
Price-to-Tangible-Book
--
--
--
--
--
--
--
800
--
--
--
--
--
37.15
--
--
-- Price-to-Free-Cash-Flow
9.09
7.98
9.80
20.82
10.02
35.57
17.17
18.36
15.29
59.22
57.85
42.23
36.25
13.09
33.87
27.38
24.59
Price-to-Operating-Cash-Flow
0.69
0.56
0.62
0.80
0.92
1.22
1.09
1.72
1.39
1.47
1.53
1.40
1.37
1.38
1.52
1.26
1.13
PS Ratio
--
--
--
2.12
2.23
4.48
13.44
68.97
--
--
11.16
--
--
51.43
--
--
-- PEG Ratio
0.86
0.90
1.00
2.22
2.24
2.55
2.47
3.44
3.00
3.22
2.30
2.61
2.37
2.22
2.51
2.32
2.19
EV-to-Revenue
10.66
11.38
10.06
22.56
17.10
21.81
22.58
28.38
24.15
27.04
6.97
48.77
24.32
15.48
44.74
24.16
22.82
EV-to-EBITDA
80.00
125
48.80
71.49
39.52
53.03
63.64
71.02
58.15
85.43
9.24
-108
85.19
27.03
-282
77.75
73.42
EV-to-EBIT
-68.87
-81.49
-52.05
-13.67
-9.34
-34.24
-15.12
1,624
-284
-24.38
-20.33
-6.61
-87.23
59.90
-36.20
-125
-118
EV-to-FCF
1.25
0.80
2.05
1.40
2.53
1.89
1.57
1.41
1.72
1.17
10.82
-0.93
1.17
3.70
-0.35
1.29
1.36
Earnings Yield (Joel Greenblatt) %
--
-2.01
37.89
15.79
12.59
13.20
1.64
0.20
-1.42
-3.92
15.27
-6.76
-8.46
-2.12
-14.39
-15.50
-16.19
Forward Rate of Return (Yacktman) %
--
--
--
--
--
--
--
753
442
819
66.17
64.83
76.65
68.23
84.77
78.97
70.78
Shiller PE Ratio
--
--
--
--
--
--
2.89
4.55
4.10
4.25
4.32
3.49
3.52
3.86
3.48
2.92
2.62
Cyclically Adjusted PB Ratio
--
--
--
--
--
--
1.47
2.10
1.77
1.74
1.86
1.61
1.75
1.93
1.77
1.49
1.34
Cyclically Adjusted PS Ratio
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2.51
--
-- Dividend Yield %
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-4.53
--
-1.67
FCF Yield %

Valuation and Quality

Dec09
Dec10
Dec11
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Dec24
TTM Fiscal Period
--
--
--
--
--
--
--
--
--
--
--
--
--
--
1,685
--
1,356
Market Cap
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2,804
--
1,496
Enterprise Value
--
--
--
--
--
--
--
--
--
--
--
--
--
--
20.00
--
20.00
Month End Stock Price
-1.67
-3.89
-3.94
-9.75
-11.66
-13.82
-14.36
-18.08
-18.47
-19.48
-9.67
-14.95
-15.22
-15.84
-17.61
-19.12
-19.15
Net Cash per Share
-0.53
-2.24
-2.05
-7.59
-9.19
-11.27
-11.63
-15.37
-15.78
-16.46
-6.61
-11.65
-11.10
-11.96
-13.85
-15.36
-15.38
Net Current Asset Value
-1.05
-2.90
-2.85
-8.54
-10.37
-12.64
-13.10
-16.85
-17.19
-18.14
-8.20
-13.36
-13.31
-14.12
-15.63
-17.12
-17.15
Net-Net Working Capital
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-4.11
--
-- Intrinsic Value: Projected FCF
--
--
--
--
--
--
--
--
--
--
--
--
--
--
19.16
--
25.72
Median PS Value
1.72
--
1.24
2.34
3.41
2.80
2.12
1.49
--
--
2.45
--
--
3.77
--
--
-- Graham Number
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-30.77
--
-41.88
Earnings Power Value (EPV)
2.34
1.53
1.55
0.60
0.74
0.98
0.80
0.89
0.82
0.79
2.27
1.10
1.31
1.72
1.37
1.15
1.10
Altman Z-Score
5.00
3.00
6.00
5.00
6.00
5.00
5.00
5.00
4.00
3.00
7.00
3.00
5.00
7.00
4.00
6.00
6.00
Piotroski F-Score
-3.30
-3.03
-2.43
-1.32
-2.46
-2.40
-2.52
-2.15
-2.70
-2.42
-1.03
-2.71
-2.31
-2.57
-2.76
-2.57
-2.57
Beneish M-Score
0.34
0.95
0.68
3.26
1.09
0.92
0.84
0.98
0.84
0.85
0.49
1.11
0.86
0.80
0.88
0.85
0.89
Scaled Net Operating Assets
0.53
8.47
6.12
15.54
16.70
6.81
5.76
9.97
-0.23
3.56
-8.31
15.78
2.28
0.07
-6.33
0.64
0.64
Sloan Ratio %
0.86
0.73
0.73
0.44
0.56
1.63
0.84
1.30
0.83
0.78
1.09
0.80
0.70
1.14
0.96
0.57
0.57
Current Ratio
0.77
0.64
0.67
0.40
0.52
1.51
0.77
1.19
0.76
0.72
0.98
0.73
0.64
1.04
0.87
0.51
0.51
Quick Ratio
0.14
0.09
0.14
0.03
0.09
0.35
0.05
0.14
0.12
0.10
0.16
0.17
0.12
0.23
0.22
0.07
0.07
Cash Ratio
0.98
0.65
2.97
2.24
1.86
1.38
1.09
1.30
1.19
0.61
--
--
0.46
0.30
--
--
-- Interest Coverage
--
--
--
--
--
--
--
--
--
--
--
--
--
--
20.25
--
20.00
Highest Stock Price
--
--
--
--
--
--
--
--
--
--
--
--
--
--
20.00
--
20.00
Lowest Stock Price
-9.92
--
-12.90
-80.32
-13.52
-0.42
-4.31
-0.05
-2.98
-0.13
-3.75
-3.39
-1.46
-0.19
0.18
--
0.19
Shares Buyback Ratio %
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.27
--
0.22
Buyback Yield %
12.37
53.21
6.78
11.56
5.91
-6.89
0.11
-3.47
16.58
-1.70
11.27
8.31
14.23
18.83
-5.58
4.29
5.76
YoY Rev. per Sh. Growth
2,300
-302
107
335
108
-48.05
-37.50
-46.00
-144
-825
2,016
-121
88.00
1,472
-173
100.00
97.95
YoY EPS Growth
-0.59
49.41
34.26
11.06
41.04
-17.04
-6.36
7.15
19.34
-5.88
209
-82.42
107
74.96
-63.04
78.56
82.36
YoY EBITDA Growth
--
--
--
29.41
21.44
20.73
11.50
6.40
5.36
2.47
22.01
2.52
-1.54
3.18
-8.23
-9.50
-9.50
5-Year EBITDA Growth Rate
29.85
30.57
30.73
48.90
62.86
71.12
73.21
74.82
76.55
77.31
77.94
80.19
83.80
84.41
84.34
--
-- Shares Outstanding (Basic Average)
31.00
31.00
35.00
63.11
71.65
71.95
75.05
75.08
77.32
77.42
80.33
83.05
84.26
84.42
84.26
84.26
84.11
Shares Outstanding (EOP)
08/21/10
05/04/11
05/02/12
04/30/13
04/30/14
04/30/15
04/30/16
03/27/17
03/29/18
03/29/19
03/27/20
03/26/21
03/30/22
03/31/23
03/28/24
04/03/25
  Filing Date
05/04/11
05/02/12
04/30/13
04/30/14
04/30/15
04/30/16
03/27/17
03/29/18
03/29/19
03/27/20
03/26/21
03/30/22
03/31/23
03/28/24
04/03/25
04/03/25
  Restated Filing Date
547
832
814
1,435
1,858
2,513
2,587
2,856
2,927
2,848
3,429
3,532
4,267
3,902
4,033
4,000
4,000
Number of Employees
* All financial numbers are in millions except for per share data, ratios and percentage change.
GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Business & Geographic Segmentation

Business Segments

Dec09
Dec10
Dec11
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Dec24
TTM Fiscal Period
--
--
--
--
--
--
--
--
--
--
544
615
708
854
750
768
-- Health care
--
--
--
--
--
--
--
--
--
--
70.67
81.86
124
166
197
211
-- Hospitality
--
--
--
--
--
--
--
--
--
--
89.89
103
117
130
139
143
-- External services
--
--
--
--
--
--
--
--
--
--
226
1.63
4.80
65.64
3.04
49.44
-- Corporate
--
--
--
--
--
--
--
--
--
--
34.54
17.38
22.74
24.25
27.99
34.60
-- Real estate
--
--
--
--
--
--
--
--
--
--
20.27
17.06
13.08
11.03
11.95
11.42
-- Others
--
--
--
--
--
--
--
--
--
--
-36.38
-11.58
-18.28
-22.10
-27.01
-31.93
-- Eliminations

Geographic Segments

Dec09
Dec10
Dec11
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Dec24
TTM Fiscal Period
--
--
--
--
--
--
--
581
672
663
950
825
972
1,229
1,102
1,186
-- Switzerland
* All financial numbers are in millions except for per share data, ratios and percentage change.
GuruFocus Manual of Stocks™  |  Jul 01, 2025
Aevis Victoria SA (OTCPK:AEVIF)
www.gurufocus.com/stock/OTCPK:AEVIF/summary

Explanation

1. Predictability Rank

GuruFocus Predictability Rank is a proprietary ranking of the consistency of a business. We rank the predictability of companies based on the consistency of their revenue per share and EBITDA (earnings before interest, tax, depreciation and amortization) per share over the past 10 fiscal years. Our study found that there is a strong correlation between the stock performance and the predictability of a business. Over the long term, companies with higher predictability also have better stock performance.

The rank is from 1-star to 5-star, with 5-star as the best.

2. Financial Strength

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

  1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
  2. Debt to revenue ratio. The lower, the better.
  3. Altman Z-Score.

The rank is from 1 to 10, with 10 as the highest.

A Financial Strength rank of 8 or above indicates good financial strength; between 4-7 indicates fair financial strength; 3 or below means poor financial strength.

3. Profitability Rank

GuruFocus Profitability Rank indicates how profitable a company is and how likely it is that the company's business will stay that way. It is based on these factors:

  1. Operating Margin %.
  2. Piotroski F-Score.
  3. Trend of the Operating Margin percentage (five-year average). A company with an uptrend in profit margin will have a higher rank.
  4. Consistency of the profitability.
  5. Predictability Rank.

The rank is from 1 to 10, with 10 as the highest.

A Profitability Rank of 8 or above indicates good profitability; between 4-7 indicates fair profitability; 3 or below means poor profitability.

4. Peter Lynch Chart

In Peter Lynch's excellent book, "One Up on Wall Street," he used many charts to illustrate the valuation of stocks. “A quick way to tell if a stock is overpriced is to compare the price line to the earnings line. If you bought familiar growth companies – such as Shoney’s, The Limited, or Marriott – when the stock price fell well below the earnings line, and sold them when the stock price rose dramatically above it, the chances are you’d do pretty well.”

The original Peter Lynch Chart does have limitations due to the right side price scale is pre-set at 15 times the earnings scale on the left side. When the stock price and earnings line coincide, the price-to-earnings ratio is always 15 times. Instead of using the fixed PE Ratio of 15, our approach is using 15-year historical median PE without NRI Ratio for each stock.

The Peter Lynch Chart with earnings line at median PE without NRI ratio works well for the companies with steady growth and earnings trends, or the stalwarts, as coined by Lynch. These companies tend to be found in sectors such as consumer staples, healthcare, and utilities, where the consumption of the product or service is relatively independent of economic conditions. It does not work well with the sectors that are cyclical: industrials, chemicals, durable goods, and so forth.

5. GF Value

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

  1. Possible Value Trap, Think Twice
  2. Significantly Overvalued
  3. Modestly Overvalued
  4. Fairly Valued
  5. Modestly Undervalued
  6. Significantly Undervalued
There is only a sufficient margin of safety when the stock is undervalued.

Disclaimer

GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.